USP Grade Pharmaceutical Raw Materials 99%Min Idebenone for Cerebral Infarction

USP Grade Pharmaceutical Raw Materials 99%Min Idebenone for Cerebral Infarction

Basic info:

Idebenone

CAS: 58186-27-9

Chemical name: 6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone

Molecular formula: C19H30O5

Molecular weight: 338.44

Melting point: (52- 55 °C )

Loss on drying: ≤ 0.5%

Relevant impurities(HPLC ): ≤ 0.8%

Content(HPLC ): ≥ 99.5%

Packing specification: 5Kg / tin, 25Kg / tin

Storage: Sealed and stored at room temperature.

Executive standard:Enterprise standard

Appearance: Orange yellow or orange crystalline powder, odorless, flavorless.

Property: This product is orange yellow or orange crystalline powder, soluble in methanol, ethanol, insoluble in water, odorless, flavorless.

Used for cerebral infarction, cerebral hemorrhage and cerebral artery sclerosis associated with depression, such as language barriers and intelligence impairment, etc.

Product introduction:

Idebenone is a kind of new drug for treating senile dementia and improving mental symptom. Also, it is a better antioxidant in cosmetics and health care than Coenzyme Q10 and Vitamin.

Idebenone is a modified version of coenzyme Q10 (CoQ10), which is absolutely crucial for metabolic function. Without it, the electron respiratory chain breaks and cells cannot produce energy. It is also the only lipid-soluble antioxidant that is synthesized in our bodies. Natural levels of CoQ10 begin to decrease after age 30.

CoQ10 would be a perfect supplement for athletes that expend excessive energy or push the anaerobic envelope were it not for one important detail: under hypoxic conditions (like going anaerobic), CoQ10 becomes pro-oxidative and creates a powerful free radical that can damage DNA, mitochondria, and lipid membranes.

There is a synthetic variation of CoQ10 called ubiquinol, also known as idebenone. It has been formulated to have all the advantages of CoQ10 without the pro-oxidative drawback.